The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 9 3010-3012
Copyright © 1999 by The Endocrine Society
Cushings Disease Presenting with Avascular Necrosis of the Hip: An Orthopedic Emergency
Christian A. Koch,
Constantine Tsigos,
Nicholas J. Patronas and
Dimitris A. Papanicolaou
Developmental Endocrinology Branch, National Institutes of Child
Health and Human Development (C.A.K., D.A.P.); Department of Radiology,
Clinical Center (N.J.P.); National Institutes of Health, Bethesda,
Maryland 20892; and National Diabetes Center (C.T.), Athens,
Greece
Address all correspondence and requests for reprints to: Dimitris A. Papanicolaou, M.D., Developmental Endocrinology Branch, National Institutes of Child Health and Human Development, National Institutes of Health, Building 10, Room 10N262, 10 Center Drive MSC 1862, Bethesda, Maryland 20892-1862. E-mail: papanicd{at}mail.nih.gov
 |
Abstract
|
|---|
Nontraumatic avascular necrosis (AVN) of the hip is commonly caused by
exogenous glucocorticoid administration, whereas it has rarely been
associated with endogenous hypercortisolism. We report a 30-yr-old
woman with Cushings disease whose presenting manifestation was early
AVN of the hip. Although plain x-ray was negative, magnetic resonance
imaging (MRI) of the hip showed stage 2 AVN. Her orthopedic
disease was considered an emergency, and thus, it was treated with core
decompression before the diagnosis of Cushings syndrome (CS) was
pursued further. The femur recovered fully, as demonstrated by her
improved clinical picture and a subsequent MRI. AVN carries a poor
prognosis, if not treated early. The diagnostic procedure of choice is
MRI, because plain radiographs are falsely negative in early stages.
This case illustrates that AVN can be the presenting manifestation of
CS; to prevent irreversible effects on the femoral head, core
decompression should not be delayed for the purpose of evaluation and
treatment of CS.
 |
Case Report
|
|---|
A 30-yr-old, previously healthy Greek woman
presented with severe left hip pain of sudden onset. She had had no
history of trauma. Apart from bromazepam at bedtime, she was on no
other medications. She had never been treated with oral, inhaled, or
locally applied corticosteroids. She did not smoke or drink alcohol.
Review of systems revealed weight gain, hypertension, hirsutism,
amenorrhea, easy bruising, insomnia, and mood swings over the previous
year. On physical examination, she was afebrile and had a blood
pressure of 157/110 mm Hg, centripetal obesity, a small buffalo hump
and supraclavicular fat pads, mild acne, and hirsutism. Range of motion
of her left hip joint was decreased, compared with the right hip joint.
Though the plain radiograph of the hip was negative, magnetic resonance
imaging (MRI) of the left femur showed a stage 2 avascular necrosis
(AVN) of the femoral head, with stage 1 being the earliest and stage 6
the most advanced (1) (Fig. 1
).
Cushings syndrome (CS) was suspected, based on her clinical
presentation. Urinary free cortisol excretion was 1258 nmol/day =
456 µg/day (normal range, 55331 nmol/day = 20120 µg/day).
At that time, it was felt that, to avoid further deterioration of her
AVN, she should have hip surgery before addressing her CS. Therefore,
she underwent immediate core decompression surgery with decongestion of
the left femoral head. She had good wound healing, with an uneventful
postoperative course.

View larger version (137K):
[in this window]
[in a new window]
|
Figure 1. Two consecutive axial inversion recovery MRI
images of both hips. Abnormal high intensity signal changes are noted
in the bone marrow of the left femoral head. Joint effusion is also
noted in the left hip (arrows). These findings are most
consistent with the diagnosis of early AVN (stage 2).
|
|
Four months after hip surgery, she was referred to the National
Institutes of Health Clinical Center for evaluation of her
hypercortisolism. At that time, her hip examination was normal. In
particular, there was no trochanteric tenderness or hip pain on inner
or outer rotation. Twenty-four-hour urinary free cortisol levels ranged
from 690-1504 nmol/day = 250545 µg/day (normal range, 66298
nmol/day = 24108 µg/day), and there was absence of diurnal
serum cortisol rhythm. A CRH stimulation test and an overnight
8-mg-dexamethasone suppression test were indicative of Cushings
disease. An MRI of the pituitary gland showed no adenoma. Inferior
petrosal sinus sampling showed lateralization to the right side, before
and after stimulation with CRH. The patient underwent transsphenoidal
surgery, with removal of a noninvasive 3-mm right-sided pituitary
microadenoma that stained positively for ACTH. Postoperatively, both
plasma and urinary cortisol concentrations became undetectable. The
patient had also a repeat MRI of the pelvis, which demonstrated an
increased signal intensity of the left femoral head, indicating
significant improvement, compared with the original MRI (Fig. 2
).

View larger version (153K):
[in this window]
[in a new window]
|
Figure 2. Two consecutive MRI images of both hips,
using a similar inversion recovery technique, 4 months after core
decompression of the left femoral head and neck. There is complete
reversal of the signal abnormality noted on the preoperative
examination. The normal contour of the left femoral head is well
preserved. There is no evidence of joint effusion.
|
|
 |
Discussion
|
|---|
This case demonstrates that AVN of the hip can be the presenting
manifestation of Cushings disease. AVN is mediated by interosseous
hypertension followed by intramedullary venous stasis, edema, necrosis,
fibrosis, and infarction that finally leads to collapse of the femoral
head (2). The most common causes of nontraumatic AVN are exogenous
glucocorticoid administration and alcoholism (3). Though AVN of the hip
is a well-recognized complication of steroid treatment (4), it has
rarely been reported in cases of endogenous hypercortisolism. To our
knowledge, only 14 patients with AVN, associated with endogenous CS,
have been documented in the medical literature (5, 6, 7, 8, 9, 10, 11, 12, 13). In one of the
largest series of corticosteroid-induced AVN (7), 3 of 77
patients (4%) were found to suffer from endogenous CS. In the same
series, exogenous glucocorticoid administration accounted for
approximately 31% of nontraumatic AVN, whereas alcohol intake
accounted for 33% of the cases. Interestingly, 32% of patients with
glucocorticoid-induced AVN were alcoholic as well.
The pathogenesis of AVN in hypercortisolism is still unknown. One
favored theory suggests that fat embolization from the liver, from bone
marrow fat cells, or from destabilization and coalescence of plasma
lipoproteins may be responsible. Another possibility is that
corticosteroids and the associated insulin resistance favor the
development of hypertension and arteriosclerosis, making AVN a
so-called coronary disease of the hip (14). Finally, it has been
suggested that osteoporosis caused by corticosteroid exposure increases
the risk of AVN, because of glucocorticoid-induced microfractures in
the susceptible bones. However, the incidence of AVN is not increased
in noncorticosteroid-related osteoporosis, making the latter an
unlikely explanation. The fact that even short-term exposure to
corticosteroids can lead to AVN (15, 16, 17) suggests that additional
mechanisms must be invoked besides the above, all of which would
presume a longer exposure to glucocorticoids. Of all sites, the femoral
head seems to be more susceptible to AVN, probably because of its
limited blood supply through the delicate artery of the ligamentum
teres, which is a terminal vessel arising from the obturator
artery.
In the past, a number of features have been used to diagnose AVN by
conventional radiography. These radiographic abnormalities, however,
occur in advanced stages of the disease, when a therapeutic
intervention would have little or no impact. Recent evidence shows that
MRI allows diagnosis of AVN at the early stages of the disease (1). In
our patient, MRI revealed stage 2 necrosis of the femoral head, whereas
the plain radiographs were negative. Because AVN very rarely develops
in the absence of trauma or other factors, such as exogenous
glucocorticoids, alcoholism or liver disease, we concluded that the AVN
diagnosed in our patient, without such predisposing risk factors,
was attributable to endogenous hypercortisolism.
AVN carries a poor prognosis if not treated early. In a recent series,
only 31% of patients with precollapse AVN had a satisfactory clinical
result without an operative procedure (18). Thus, early surgical
intervention would be necessary to avoid permanent abnormalities of the
femoral head and hip. Surgical treatment options are dependent on the
stage of the disease, and they include core decompression, bone
grafting, various osteotomies, and total hip replacement (1). In
precollapse stages, as in our case, core decompression is the most
effective form of treatment (2). Core decompression decreases the
pressure within the medulla of the head and neck of the femur and
potentially leads to improved circulation to the femoral head (1).
In summary, this case illustrates that AVN, an orthopedic emergency,
can be the presenting manifestation of Cushings disease. Thus, CS
should be suspected in every patient that presents with AVN in the
absence of other predisposing factors, such as alcohol abuse or
exogenous glucocorticoid administration. On the other hand, AVN should
be suspected in any patient with CS presenting with sudden hip pain. In
such a case, an MRI must be obtained for confirmation because plain
radiographs are falsely negative in early stages. Once the diagnosis is
established, core decompression of the femoral head should be
performed. Such surgical intervention in early AVN should generally
precede treatment of CS, for the purpose of preventing irreversible
effects on the femoral head. Nevertheless, this approach should be
individualized, depending on the severity of CS.
Received March 22, 1999.
Accepted June 9, 1999.
 |
References
|
|---|
-
Mazieres B. 1998 Regional and heritable bone
and collagen diseases. Osteonecrosis. In: Klippel JH, Dieppe PA, eds.
Rheumatology. 2nd ed. London: Mosby International; 8.47.18.47.10.
-
Smith SW, Ferhing TK, Griffin WL, Beaver WB. 1995 Core decompression of the osteonecrotic femoral head. Am J Bone Joint
Surg. 77:674680.[Abstract/Free Full Text]
-
Ninomiya S. 1989 An epidemiological survey of
idiopathic avascular necrosis of the femoral head in Japan. Annual
report of the Japanese Investigation Committee for Intractable Disease.
Osaka: University Publisher.
-
Thornton MJ, OSullivan G, Williams MP, Hughes
PM. 1997 Avascular necrosis of bone following an intensified
chemotherapy regimen including high dose steroids. Clin Radiol. 52:607612.[CrossRef][Medline]
-
Madell SH, Freeman LM. 1964 Avascular necrosis of
bone in Cushings syndrome. Radiology. 83:10681070.
-
Patterson RJ, Bickel WH, Dahlin DC. 1964 Idiopathic avascular necrosis of the head of the femur. Am J Bone Joint
Surg. 46:267282.[Free Full Text]
-
Fisher DE, Bickel WH. 1971 Corticosteroid induced
avascular necrosis. Am J Bone Joint Surg. 53:859873.[Abstract/Free Full Text]
-
Modlinger RS, Nicolis GL, Pertsemlidis D, Gabrilove
JL. 1972 Cushings syndrome and avascular necrosis of bone
associated with carcinoid-islet cell tumor of the pancreas. Cancer. 30:782790.[CrossRef][Medline]
-
Cerletty JM, Ziebert AP, Mueller KH. 1973 Avascular necrosis of the femoral head as the presenting manifestation
of Cushings disease. Clin Orthop. 97:6973.
-
Sharon P, Kaplinsky N, Leiba S, Frankl O. 1977 Aseptic necrosis of head of femur: presenting manifestation in
Cushings disease. J Rheumatol. 4:7375.[Medline]
-
Phillips KA, Nance Jr EP, Rodriguez RM, Kaye JJ. 1986 Avascular necrosis of bone: a manifestation of Cushings disease. South Med J. 79:825829.[Medline]
-
Wicks IP, Calligeros D, Kidson W, Bertouch JV. 1987 Cushings disease presenting with avascular necrosis of the femoral
heads and complicated by pituitary apoplexy. Ann Rheum Dis. 46:783786.[Abstract/Free Full Text]
-
Kobayashi S, Terayama K. 1991 Osteoarthritis
secondary to avascular necrosis of the femoral head as a manifestation
of Cushings disease (French). Rev Chir Orthop Reparatrice Appar Mot. 77:362365.[Medline]
-
Hungerford DS, Zizic TM. 1983 Pathogenesis of
ischemic necrosis of the femoral head. In: Hungerford DS, ed. The hip.
Proc of the 11th Open Scientific Meeting of The Hip Society. St. Louis:
CV Mosby; 249256.
-
Williams PL, Corbett M. 1983 Avascular necrosis of
bone complicating corticosteroid replacement therapy. Ann Rheum Dis. 42:276279.[Abstract/Free Full Text]
-
Taylor LJ. 1984 Multifocal avascular necrosis after
short-term high-dose steroid therapy. A report of three cases. Br J
Bone Joint Surg. 66:431433.
-
Solomon L, Pearse MF. 1994 Osteonecrosis following
low-dose, short-course corticosteroids. J Orthop Rheumatol. 7:203205.
-
Mont MA, Hungerford DS. 1995 Non-traumatic
avascular necrosis of the femoral head. Am J Bone Joint Surg. 77:459474.[Free Full Text]